Long‐term foscarnet therapy not associated with the development of foscarnet‐resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient

Gilda Tachedjian, Jenny Hoy, Kate McGavin, Chris Birch

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)207-211
Number of pages5
JournalJournal of Medical Virology
Volume42
Issue number2
DOIs
Publication statusPublished - 1 Jan 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AIDS
  • drug resistance
  • foscarnet
  • HIV‐1
  • zidovudine

Cite this